Make Informed Investment Decisions with Affordable Access to Experts

This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Another Perspective: Understanding Tumor Infiltrating Lymphocytes (TIL) therapy currently being developed by Iovance

Ticker(s): IOVA

Who's the expert?

Name: Dr Qiao Li - PhD.

Institution: University of Michigan

  • Research Associate Professor & member of the Tumor Immunology Program at the University of Michigan Medical Cancer Center with over 20 years of experience.
  • Research focuses on the generation of tumor-reactive T cells for the adoptive immunotherapy of cancer centering on developing new strategies for T cell activation /expansion using monoclonal antibodies and recombinant cytokines.
  • A novel protocol based on Dr. Li's effort utilizing anti-CD3/anti-CD28 activated T cells is funded by NIH and is now being used in a clinical trial to treat renal cell cancers at the University of Michigan Medical Center.

Interview Questions
Q1.

Please describe your clinical practice as it relates to cancer immunotherapies.

Added By: c_admin
Q2.

Can you briefly explain TIL as a mechanism of action?

Added By: c_admin
Q3.

What are your thoughts on Tumor Infiltrating Lymphocytes (TIL) therapy currently being developed by Iovance?

Added By: c_admin

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.